14839977

NETTER A

1951

[Febrile forms of sclerocystic ovary].

14872028

Mikkonen K

2004

Long-term reproductive endocrine health in young women with epilepsy during puberty.

14894126

PLATE WP

1951

Hirsutism in ovarian hyperthecosis.

14964181

Kordella T

2002

Research profile. A tale of two conditions.

14966390

Franks S

2004

Genetics of ovarian disorders: polycystic ovary syndrome.

14967373

Maciel GA

2004

Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.

14967374

Panidis D

2004

Serum resistin levels in women with polycystic ovary syndrome.

14967392

Vanky E

2004

Dexamethasone reduces androgen levels in metformin-treated patients with polycystic ovary syndrome.

14968492

Kauffman MM

2003

Polycystic ovary syndrome--a complex disorder among women.

14973405

Carmina E

2004

Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines.

14973406

Belosi C

2004

[Diagnosis of polycystic ovary syndrome].

14973407

Ajossa S

2004

The treatment of polycystic ovary syndrome.

14973408

Talbott EO

2004

Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.

14973409

Pelusi B

2004

Type 2 diabetes and the polycystic ovary syndrome.

14973410

De Leo V

2004

Polycystic ovary syndrome and type 2 diabetes mellitus.

14973411

Barbieri RL

2004

Metformin for the treatment of the polycystic ovary syndrome.

14973957

Bayram N

2004

Pulsatile gonadotrophin releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome.

14975970

Park SJ

2004

Diagnosis of pelvic congestion syndrome using transabdominal and transvaginal sonography.

14976888

Shao RY

2004

[Clinical observation on treatment of Stein-Leventhal syndrome caused sterility by combined use of clomiphene and Chinese nourishing shen and activating blood circulation drugs].

14979602

Mueck AO

2004

Hormone therapy after endometrial cancer.

14980990

Dobie DJ

2004

Posttraumatic stress disorder in female veterans: association with self-reported health problems and functional impairment.

14984444

Ben-Haroush A

2004

Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes.

14984768

Ferrara N

2004

EG-VEGF and Bv8: a novel family of tissue-restricted angiogenic factors.

14988311

Bloomgarden ZT

2004

Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome.

14992162

Luboshitzky R

2003

Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women with polycystic ovary syndrome: the effect of ethinyl estradiol-cyproterone acetate treatment.

14992163

Kahsar-Miller MD

2003

The effectiveness of the interview for predicting the presence of polycystic ovary syndrome.

14992541

Lee JC

2003

The effect of herbal medicine on nerve growth factor in estradiol valerate-induced polycystic ovaries in rats.

14998943

de Boer JA

2004

Growth hormone secretion is impaired but not related to insulin sensitivity in non-obese patients with polycystic ovary syndrome.

14998944

Glueck CJ

2004

Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy.

14998946

Vanky E

2004

Six-month treatment with low-dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and metformin.

14998947

Guido M

2004

Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.

15001622

Diamanti-Kandarakis E

2004

Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome.

15004406

Yarman S

2004

The prevalence, molecular analysis and HLA typing of late-onset 21-hydroxylase deficiency in Turkish woman with hirsutism and polycystic ovary.

15008257

Carmina E

2003

Genetic and environmental aspect of polycystic ovary syndrome.

15008997

Kaushal R

2004

Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries.

15010188

Kafali H

2004

Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease.

15010862

Buchs A

2004

Normal p21Ras/MAP kinase pathway expression and function in PBMC from patients with polycystic ovary disease.

15012623

Janssen OE

2004

High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome.

15015150

Salehi M

2004

Pathogenesis of polycystic ovary syndrome: what is the role of obesity?

15016769

Homburg R

2004

Polycystic ovary syndrome in adolescence--a therapeutic conundrum.

15018436

Buckett WM

2004

Human chorionic gonadotropin for in vitro oocyte maturation: does it improve the endometrium or implantation?

15024892

Buccola JM

2003

Polycystic ovary syndrome: a review for primary providers.

15031776

Luboshitzky R

2004

Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.

15033943

Cibula D

2004

Is insulin resistance an essential component of PCOS?: The influence of confounding factors.

15037399

Kirchengast S

2004

Body composition characteristics and fat distribution patterns in young infertile women.

15037412

Belli SH

2004

Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome.

15037413

Stamets K

2004

A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome.

15044401

Taponen S

2004

Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.

15046638

Stener-Victorin E

2004

Effect of electro-acupuncture stimulation of different frequencies and intensities on ovarian blood flow in anaesthetized rats with steroid-induced polycystic ovaries.

15052762

Aherne SA

2004

Polycystic ovary syndrome.

15053246

Orio F Jr

2004

Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism?

15053248

Guido M

2004

Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: a case report.

15053331

Dravecka I

2003

Obesity is the major factor determining an insulin sensitivity and androgen production in women with anovulary cycles.

15054879

Kumazawa T

2004

Microsatellite polymorphism of steroid hormone synthesis gene CYP11A1 is associated with advanced prostate cancer.

15055472

G?ll? S

2003

Diagnostic value of prostatic specific antigen in hirsute women.

15057670

Wa?ko R

2004

Elevated ghrelin plasma levels in patients with polycystic ovary syndrome.

15058905

Ozanne SE

2004

Fetal growth and adult diseases.

15059032

Rold?n B

2004

Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy.

15059163

Vanky E

2004

Clinical, biochemical and ultrasonographic characteristics of Scandinavian women with PCOS.

15063962

Pawelczyk L

2004

Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.

15063963

Sahin Y

2004

The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome.

15065633

Kearns AE

2004

Potential anabolic effects of androgens on bone.

15066469

Chauhan S

2004

Effect of gonadotropin-releasing hormone hypogonadism on insulin action as assessed by hyperglycemic clamp studies in men.

15067828

Abbasi AU

2003

Minilaparotomy and ovarian diathermy drilling for clomiphene resistant poly cystic ovarian disease.

15067892

Laboureau-Soares Barbosa S

2003

[New medical treatments for polycystic ovary syndrome].

15070878

Farquhar CM

2004

An economic evaluation of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene citrate resistant polycystic ovary syndrome.

15070917

Ib??ez L

2004

Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.

15072549

Arlt W

2004

Cinnamic acid based thiazolidinediones inhibit human P450c17 and 3beta-hydroxysteroid dehydrogenase and improve insulin sensitivity independent of PPARgamma agonist activity.

15073141

Jonard S

2004

The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.

15073142

Wu R

2004

Macrophage contributions to ovarian function.

15073145

Forges T

2004

Autoimmunity and antigenic targets in ovarian pathology.

15080783

M?hlig M

2004

The polycystic ovary syndrome per se is not associated with increased chronic inflammation.

15087595

Vrb?kov? J

2004

Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome.

15096602

Sullivan SD

2004

Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder.

15096648

Salmi DJ

2004

Screening for and treatment of polycystic ovary syndrome in teenagers.

15104558

Wijeyaratne CN

2004

Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?

15106360

Szil?gyi A

2004

Low-dose ovulation induction with urinary gonadotropins or recombinant follicle stimulating hormone in patients with polycystic ovary syndrome.

15107259

Mueck AO

2003

Hormone therapy after endometrial cancer.

15107936

Mendon?a HC

2004

Positive correlation of serum leptin with estradiol levels in patients with polycystic ovary syndrome.

15114893

Frederick J

2004

Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.

15115425

Simmons D

2004

Metformin therapy and diabetes in pregnancy.

15115430

Proietto J

2004

10: Management of obesity.

15117017

Rao SS

2004

Impaired glucose tolerance and impaired fasting glucose.

15117896

Glueck CJ

2004

Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.

15117902

Kj?tr?d SB

2004

Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study.

15118266

Takeuchi T

2004

Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction.

15118487

Rasgon N

2004

The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence.

15121620

Dahan MH

2004

Tumor-level serum testosterone associated with human immunodeficiency virus lipodystrophy syndrome.

15122838

Hoeger KM

2004

Review: metformin used alone or combined with clomifene may improve ovulation rates in the polycystic ovary syndrome.

15123054

Khalid A

2004

Irregular or absent periods--what can an ultrasound scan tell you?

15123116

Lefebvre P

2004

[Long-term risks of polycystic ovaries syndrome].

15123128

Fernandez H

2004

[Two complications of ovarian drilling by fertiloscopy; Gyn?col Obst?t Fertil 2003; 31: 844-846].

15126528

Taponen S

2004

Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.

15126536

Boulman N

2004

Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease.

15126571

Gaasenbeek M

2004

Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone.

15129050

Chian RC

2004

State of the art in in-vitro oocyte maturation.

15129054

Norman RJ

2004

Should we continue or stop insulin sensitizing drugs during pregnancy?

15130373

Gao JS

2004

[Clinical analysis of endometrial carcinoma patients aged 45 years and younger].

15130377

Zhang CL

2004

[Effect of rosiglitazone on ovulation induction in women with polycystic ovary syndrome].

15130378

Chu YL

2004

[Tyrosine phosphorylation and protein expression of insulin receptor substrate-1 in the patients with polycystic ovary syndrome].